Abstract:BACKGROUND: Quinacrine (QC), an antimalarial drug, has been shown to possess anticancer effect both in vitro (cancer cell lines) and in vivo (mouse models). In the cancer cells, QC can simultaneously suppress nuclear factor-kappa B and activate p53 signaling, which results in the induction of the apoptosis in these cells. However, the experimental results come from a few limited cancer cell lines, and the detailed mechanisms remain unknown.OBJECTIVE: This study investigated the tumor-killing effects of QC on gastric cancer cells as well as underlying molecular pathways.METHODS: SGC-7901 cells were treated with or without QC at different concentrations for 24 hours. The effect of QC on the inhibition of SGC-7901 cell proliferation was assessed by Cell Counting Kit-8 assay. Apoptosis was detected by examining nuclear morphology and quantifying phosphatidylserine externalization. Alterations in cellular morphology were analyzed by laser scanning confocal microscopy for fluorescent analysis. Cell cycle analysis was performed by propidium iodide (PI) staining and flow cytometry. The enzyme activity changes of caspase-3 were detected by colorimetry expression method. Western blot analysis was used to detect the changes in the protein level of Bax, Bcl-2, p53, and cytochrome c in cytosol of SGC-7901 cells.RESULTS: Our results showed that QC could significantly inhibit the growth of SGC-7901 cells in a dose-dependent manner, with the IC50 mean (SD) value of 16.18 (0.64) mu M, compared with nontreated controls. QC treatment (15 mu M) could also induce apoptosis in SGC-7901 cells (26.30% [5.31%], compared with control group of 3.37% [0.81%]; P <0.01), and the increasing phosphatidylserine level and the accumulation of chromatin nucleation in QC-treated cells provided further evidence. In addition, cell cycle analysis with PI staining showed that a significant S enriches, increasing from 12.00% (1.24%) (control) to 20.94% (2.40%) (QC treatment) (P < 0.01). Furthermore, increased activities of caspase-3 (increasing from 0.108 [0.019] to 0.628 [0.068]; P < 0.01) were observed in SGC-7901 cells treated with 15 mu M QC. Western blot analysis showed that QC treatment significantly increased the levels of proapoptotic proteins, including cytochrome c, Bax, and p53, and decreased the levels of antiapoptotic protein Bcl-2, thus shifting the ratio of Bax/Bcl-2 in favor of apoptosis.CONCLUSIONS: Our findings suggest that QC can significantly inhibit cell growth and induce apoptosis in SGC-7901 cells, which involves p53 upregulation and caspase-3 activation pathway. (Curr Ther Res Clin Exp. 2012;73:52-64) (c) 2012 Elsevier HS Journals, Inc. All rights reserved.

Molecular mechanisms of quinalizarin induces apoptosis and G0/G1 cell cycle of human esophageal cancer HCE‐4 cells depends on MAPK, STAT3, and NF‐κB signaling pathways

Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species‐mediated signaling pathways in human melanoma A375 cells

Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901

Quercetin Induces Apoptosis by Activating Caspase-3 and Regulating Bcl-2 and Cyclooxygenase-2 Pathways in Human HL-60 Cells

Quercetin Induced Cell Apoptosis and Altered Gene Expression in AGS Human Gastric Cancer Cells

Proliferation and apoptosis effects of thymoquinone on human gastric cancer MGC-803 cells and its mechanism

Synthesis and evaluation of anticancer activity of quillaic acid derivatives: A cell cycle arrest and apoptosis inducer through NF-κB and MAPK pathways

Thymoquinone Inhibits the Proliferation and Invasion of Esophageal Cancer Cells by Disrupting Theakt/gsk-3/Wnt Signaling Pathway Viaptenupregulation

In Vitro Effects and the Related Molecular Mechanism of Galangin and Quercetin on Human Gastric Cancer Cell Line (SGC-7901).

The effect of quercetin on cervical cancer cells as determined by inducing tumor endoplasmic reticulum stress and apoptosis and its mechanism of action

Quercetin Induces Protective Autophagy in Gastric Cancer Cells: Involvement of Akt-mTOR- and Hypoxia-Induced Factor 1Α-Mediated Signaling.

Quercetin Induced Apoptosis of Human Oral Cancer SAS Cells Through Mitochondria and Endoplasmic Reticulum Mediated Signaling Pathways

Quercetin Attenuates Quinocetone-Induced Cell Apoptosis In Vitro by Activating the P38/Nrf2/HO-1 Pathway and Inhibiting the ROS/Mitochondrial Apoptotic Pathway

The Quinazoline Derivative, 04NB-03, Induces Cell Cycle Arrest and Apoptosis in Hepatocellular Carcinoma Cells in a Reactive Oxygen Species-Dependent Manner.

Effect of a Protein Kinase CK2 Inhibitor on Intracellular Levels of Reactive Oxygen Species and DNA Double-Stand Break in H460 Cells

Quercetin-induced Apoptosis Acts Through Mitochondrial- and Caspase-3-dependent Pathways in Human Breast Cancer MDA-MB-231 Cells

Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro

Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin.

Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway

Quercetin Induces Apoptosis in HepG2 Cells Via Directly Interacting with YY1 to Disrupt YY1-p53 Interaction

Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft